Natco Pharma to commence Galtiramer Acetate production for Mylan
Natco Pharma chief financial officer P Bhaskara Narayana said that the facility which is worth INR 910m ($17.88m) is ready. "The actual production in the dedicated multiproduction block
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.